Ken Griffin Biora Therapeutics, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$0.13 - $12.03 $16,503 - $1.53 Million	126,948 Added 365.97%	161,636 $21,000
Q3 2022 Nov 14, 2022	BUY	$0.53 - $13.3 $12,162 - $305,221	22,949 Added 195.49%	34,688 $17,000
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.22 $229,722 - $500,467	-410,219 Reduced 97.22%	11,739 $8,000
Q1 2022 May 16, 2022	BUY	$1.11 - $2.25 $137,545 - $278,808	123,915 Added 41.58%	421,958 $489,000
Q4 2021 Feb 14, 2022	BUY	$1.35 - $4.89 $351,018 - $1.27 Million	260,014 Added 683.73%	298,043 $622,000
Q1 2021 May 17, 2021	BUY	$3.91 - $7.31 $148,693 - $277,991	38,029 New	38,029 $181,000
Q3 2020 Nov 16, 2020	SELL	$7.71 - $10.79 $771,000 - $1.08 Million	-100,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.0 - $13.12 $900,000 - $1.31 Million	100,000 New	100,000 $900,000

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $41.1M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.